Bjb. Simpson et al., ESTROGEN REGULATION OF TRANSFORMING GROWTH-FACTOR-ALPHA IN OVARIAN-CANCER, Journal of steroid biochemistry and molecular biology, 64(3-4), 1998, pp. 137-145
Transforming growth factor alpha (TGF alpha) may be induced by estroge
n in estrogen responsive systems and can contribute to the growth-modu
latory effects of this hormone. To test whether TGF alpha contributes
to estrogen-regulated growth in ovarian cancers, we have compared the
effects of 17 beta-estradiol (E-2) and TGF alpha in a range of ovarian
carcinoma cell lines. Addition of E-2 to the estrogen receptor (ER)-p
ositive cell lines (PE01, PE04 and pE01(CDDP)) produced a 2-4 fold inc
rease in TGF alpha protein concentrations in media conditioned by the
cells. Both E-2 and TGF alpha stimulated the growth of the PE01 and PE
04 lines and inhibited the growth of the pE01(CDDP) line. Furthermore,
the E-2-mediated growth effects could be reversed by an epidermal gro
wth factor (EGF) receptor-targeted antibody. E-2 also down-regulated E
GF receptor expression in ER-positive cell lines. In a series of prima
ry ovarian tumors, higher concentrations of ER were associated with an
increased percentage of tumors expressing TGF alpha mRNA and a decrea
sed percentage expressing EGF receptor protein. All these data are con
sistent with E-2 increasing production of TGF alpha in ER-positive ova
rian cancer and this in turn acting through the EGF receptor to modula
te growth in an autocrine manner. (C) 1998 Elsevier Science Ltd. All r
ights reserved.